Vertex Pharmaceuticals

Yahoo Finance • 10 days ago

Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating consensus for Q4 and FY24, the analyst tells in... Full story

Yahoo Finance • 10 days ago

Vertex Pharmaceuticals price target raised to $520 from $460 at Truist

Truist raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $520 from $460 and keeps a Buy rating on the shares. The firm is positive on the launch of Journavx, which is seeing “broad based support even from political foes”,... Full story

Yahoo Finance • 11 days ago

Vertex Pharmaceuticals Inc (VRTX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Revenue: $2.91 billion in Q4 2024, 16% growth versus Q4 2023. Full-Year Revenue: $11.02 billion for 2024, 12% growth versus 2023. Non-GAAP Operating Income: $1.2 billion in Q4 2024, compared to $1.15 billion in Q4 2023. Non-GAAP Earnings P... Full story

Yahoo Finance • 13 days ago

2 Biotech Stocks to Buy Hand Over Fist in February

Equity markets performed well in January, as they often do, but as the dust settles on that early-year run, the strategy for long-term investors remains the same: Invest in companies that can perform well over long periods, whether or not... Full story

Yahoo Finance • 22 days ago

AbbVie, Vertex's Journavx, Exxon and Chevron: Market Minute

Yahoo Finance host Josh Lipton breaks down the day's top trending stocks and market stories in the Market Minute. AbbVie (ABBV) shares continue to pop in Friday trading after raising its revenue guidance for new drugs Skyrizi and Rinvoq.... Full story

Yahoo Finance • 22 days ago

Vertex stock jumps on FDA approval of new non-opioid painkiller

Vertex Pharmaceuticals (VRTX) stock is rising following Food and Drug Administration (FDA) approval of Journavx, a non-opioid pain medication designed to treat moderate to severe acute pain. The new drug represents a potentially significan... Full story

Yahoo Finance • 22 days ago

How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion Chapter

Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped. Continue Reading View Comments... Full story

Yahoo Finance • last month

Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits Research

New York, United States, Jan. 22, 2025 (GLOBE NEWSWIRE) -- ADCs, or antibody-drug conjugates, are chemotherapeutic agents explicitly designed to treat cancer cells. Antibody-drug conjugates deliver chemotherapy by fusing a linker to a mo... Full story

Yahoo Finance • 5 months ago

Vertex Announces Health Canada Acceptance of New Drug Submission for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-in-Class Triple Combination Treatment for Cystic Fibrosis

TORONTO, Sept. 26, 2024 /CNW/ - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor/tezacaftor/deutivacaftor, a once-daily triple combi... Full story

Yahoo Finance • 5 months ago

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

– First regulatory authorization of a CRISPR-based gene-editing therapy in Canada – TORONTO, Sept. 25, 2024 /CNW/ - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced Health Canada has granted Marketing Authorization for P... Full story

Yahoo Finance • 5 months ago

Prediction: These 3 Phenomenal Stocks Are Set to Soar

No one knows for sure how any stock will perform over the next 12 months. There are simply too many variables that can come into play. However, that doesn't mean that analysts and investors can't have pretty good hunches about what certai... Full story

Yahoo Finance • 6 months ago

Vertex Pharmaceuticals Incorporated (VRTX): Why Do Hedge Funds Recommend This Biotech Stock?

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds.In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other biotech stocks... Full story

Yahoo Finance • 6 months ago

3 No-Brainer Stocks to Buy in September

Don't want to think too hard about your investing decisions? Then go with the stocks of highly profitable companies with strong growth prospects. Three Motley Fool contributors identified several stocks that fit this description. Here's w... Full story

Yahoo Finance • 6 months ago

Vertex Pharmaceutical Inc. (VRTX): Jim Cramer’s Go-To Stock For Success

We recently compiled a list of the Jim Cramer’s 10 Go-To Stocks for Success.In this article, we are going to take a look at where Vertex Pharmaceutical Inc. (NASDAQ:VRTX) stands against Jim Cramer's other go-to stocks for success. In a re... Full story

Yahoo Finance • 6 months ago

3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever

Almost every portfolio needs a couple of anchor stocks that tend to grow consistently over time regardless of the mood of the market or the state of the economy. Thanks to the must-buy nature of lifesaving medicines and the regular launch... Full story

Yahoo Finance • 6 months ago

Vertex to Participate in Upcoming September Investor Conferences

BOSTON, August 22, 2024--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Dr. Reshma Kewalramani, Chief Executive Officer and President, and... Full story

Yahoo Finance • 6 months ago

3 Fantastic Growth Stocks to Buy in August

The recent stock market sell-off appears to have fizzled out and now could be a great time for long-term investors to put some of their cash to work. Three Motley Fool contributors think they've found fantastic growth stocks to buy in Aug... Full story

Yahoo Finance • 6 months ago

Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them

If hockey great Wayne Gretzky received a quarter every time his most famous quote was cited, he'd probably have more money than he made during his sports career. That quote, of course, is: "I skate to where the puck is going, not where it... Full story

Yahoo Finance • 7 months ago

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now

Few healthcare companies are more famous than Johnson & Johnson(NYSE: JNJ). The pharmaceutical giant earned its stature in the industry thanks to its incredible innovative abilities and a business that's been executing for decades. Howeve... Full story

Yahoo Finance • 7 months ago

Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?

Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday? Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon i... Full story